AMS to spend $200 million on CMOSIS buy
Headquartered in Antwerp (Belgium), CMOSIS is a leading supplier of high performance standard and customized area and line scan CMOS image sensors for demanding imaging applications. CMOSIS’ portfolio of imaging solutions features low noise, global and rolling shutter, high dynamic range, and high frame rates through high-speed on-chip analog-to-digital conversion and digital interfaces.
The image sensors serve a broad range of high-end applications in diverse markets including machine vision, medical, broadcast, traffic, scientific and photographic imaging. In addition, CMOSIS offers the NanEye miniature camera module line for endoscopy-like medical applications, recently winning the German Innovation Award for Non-Clinical Intensive Care.
Founded in 2007, CMOSIS operates as a fabless semiconductor supplier from locations in Belgium, Germany, Portugal, and the U.S. and has more than 110 employees. CMOSIS expects to generate full year 2015 revenues of approx. EUR 60m with strong operating profitability above ams’ current group operating profitability. Based on available information, CMOSIS expects to continue year-on-year revenue growth in 2016.
Under the terms of the agreement, ams will acquire 100% of the shares in CMOSIS from TA Associates, a leading global growth private equity firm, and management shareholders for an equity value of approx. EUR 220m.
ams expects to fund the transaction from existing cash and available credit lines with no additional transaction-based financing.
"Acquiring CMOSIS is a highly complementary expansion of our sensor portfolio and another major step in executing our sensor solutions growth strategy. This transaction extends our market leadership in optical sensors and will strengthen our position as the leading pure-play sensor solutions provider for growth markets including Industry 4.0, IoT (Internet of Things) and medical diagnostics. Integrating cameras with advanced optical sensors will drive new sensor solutions across vertical markets and accelerate our growth plans as we combine CMOSIS’ leading edge IP and design capabilities with our manufacturing competence and optical sensor strengths", emphasized ams’ CEO, Kirk Laney in a conference call.
During a questions & answers session, the company hinted that while most of CMOSIS’ existing product lines would be maintained and produced using the already established production flow and supply chain, new products integrating CMOSIS’ imaging technology into ams’ sensors may be produced in-house, as it would usually be the case for all new and critical IP at ams.
Laney mentioned miniature endoscopy imaging sensors as interesting parts that could well be integrated with other sensors to move into new automotive or even consumer applications.
Visit ams at www.ams.com